Mr. Gisby is a senior Corporate Strategy and M&A professional with over twenty years of experience serving the Life Sciences and Health Care industries. As well as founding and leading the Life Sciences and Health Care practice at Deloitte Corporate Finance LLC, he leads The Future of Health for Deloitte Risk and Financial Advisory and co-leads the Healthcare Strategy & Growth practice.
Mr. Gisby has advised on numerous strategies, affiliations, partnerships, and M&A engagements. He is currently focusing on facilitating partnerships across the entire life science and healthcare ecosystem. His clients include global pharmaceutical and medical device companies, health insurance companies, health systems, healthcare information technology companies, and other healthcare providers
He is a frequent contributor to and author of articles and publications on healthcare strategy and M&A and has been quoted in numerous national media outlets. Mr. Gisby is a member of the New York Security Analysts Society and The Association for Investment Management Research.
Deloitte refers to one or more of Deloitte Touche Tohmatsu Limited, a UK private company limited by guarantee (“DTTL”), its network of member firms, and their related entities. DTTL and each of its member firms are legally separate and independent entities. DTTL (also referred to as “Deloitte Global”) does not provide services to clients. In the United States, Deloitte refers to one or more of the US member firms of DTTL, their related entities that operate using the “Deloitte” name in the United States, and their respective affiliates. Certain services may not be available to attest to clients under the rules and regulations of public accounting. Please see www.deloitte.com/about to learn more about our global network of member firms.
Please see www.deloitte.com/us/about for a detailed description of our legal structure.